With state-of-the-art diagnosis and treatment, there is no better place for esophageal cancer care than Virginia Mason. Virginia Mason cares for the most esophageal cancer patients in the western United States, and is seventh in the nation for esophageal cancer patient volumes.* Our high patient volumes speak to the experience and expertise of our team of esophageal physicians and nurses, and have resulted in survival outcomes that exceed national and international averages.
At Virginia Mason, patients with esophageal cancer benefit from the team approach of two programs that offer exemplary outcomes in esophageal cancer treatment. These include the Floyd & Delores Jones Cancer Institute, and the Digestive Disease Institute's Esophageal Center of Excellence.
Experienced Specialists Provide the Best Care
Our esophageal specialists at Virginia Mason are seasoned professionals that include surgeons, radiologists and medical oncologists. These physicians work with other highly skilled health-care providers such as nurses, nutritionists and social workers to create a personalized care plan for each cancer patient.
The Thoracic Oncology Tumor Board — a multi-disciplinary group of experts from thoracic surgery, medical oncology, radiation oncology, gastroenterology, radiology and pathology — reviews individual cases. These physicians are joined by other specialists as needed.
Together, the experts and specialists at Virginia Mason develop a unique plan of treatment for each patient that addresses the particular aspects of their disease. The care team will then carefully follow the patient from diagnosis through treatment and recovery.
To learn more about esophageal cancer care at Virginia Mason or to make an appointment, please call (206) 223-6193.
Internationally Recognized Esophageal Cancer Care
Virginia Mason has led the way in the surgical treatment of esophageal cancer and studies have shown that its clinical care pathways result in outcomes that can be compared favorably to other institutions throughout the world. We routinely utilize robotics and minimally invasive surgery in treatment of esophageal cancer.
A Variety of Esophageal Cancer Treatment Options
Surgery, radiation and chemotherapy are all options in the treatment of thoracic/esophageal cancer. Patients are provided with all the information they need to make an informed decision about treatment. A multidisciplinary team of specialists create a plan of care unique to each patient and his or her particular form of cancer. This treatment plan is consistently evaluated and adjusted as needed.
Personal Guidance
A cancer care manager is with each patient every step of the way, from diagnosis through recovery. The care manager is always available to answer questions and assist in coordinating every aspect of a patient's care.
Clinical Trials
Virginia Mason is relentlessly devoted to providing excellent health care. This commitment includes conducting clinical research studies that may improve the way we diagnose, treat and prevent disease. Benaroya Research Institute (BRI), oversees all clinical research at Virginia Mason, uniquely combining the expertise of a world-renowned medical research institute with the remarkable care of a health care quality leader.
For more than 20 years, the goal of our clinical research program has been to provide each of our patients with a research option at every step of their disease, from initial diagnosis to long-term follow-up. Our trials include the use of chemotherapy, radiation and targeted therapies, as well quality of life/symptom management trials. Learn more about our current esophageal cancer clinical trials.
Prompt Attention
New patients often see a physician the same day they call, allowing therapy to begin quickly. Cancer care coordinators are readily available to answer questions and expedite care.
To learn more about esophageal cancer care at Virginia Mason or to make an appointment, please call (206) 223-6193.
* Data from Commission on Cancer reporting for accredited institutions that publicly report patient volume in diagnosis year 2016.